UCLA Researchers Create Universal Single-Product Immunotherapy for Breast Cancer
Triple-negative breast cancer (TNBC) has long posed a formidable challenge within oncology, notorious for its aggressive nature and limited treatment avenues. Unlike other breast cancer...
















